How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug
•Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot.
•It was difficult to deliver, heavily regulated and slow to catch on.
•Find out how it became a billion-dollar drug and part of a new model for treating depression.
هذا الخبر من Bloomberg. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to deliver, heavily regulated and slow to catch on. Find out how it became a billion-dollar drug and part of a new model for treating depression. (Source: Bloomberg)المصدر: Bloomberg | Source: Bloomberg
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Bloomberg. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Bloomberg. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
